Room Escape: Propuesta de Gamificación en el Grado de Fisioterapia

[EN] In line with current learning theories, teaching in Higher Education increasingly employs approaches and activities that place the learner at the centre of the learning-teaching process. One such approach is gamification: the use of principles normally encountered in games in a non-game context for educational purposes. This paper considers the use of a gamification activity, Room Escape. The activity is used in the context of the subject General Procedures in Physiotherapy in the Physiotherapy degree programme at Universidad San Jorge. A Case-based Learning approach was adopted and the habitual characteristics of Escape Room activities were adapted to facilitate the desired learning outcomes. An anonymous, online questionnaire measuring the students perceptions of their learning gains and the efficacy of the activity as a learning tool, was completed by students after the activity. Results show a positive assessment, particularly in terms of the degree of motivation and effort made by students to complete the task, aspects key to successful learning. Learners recognized that they could have been better prepared for the activity but that it was indeed an activity that facilitated learning with its case-study approach and allowed them to consolidate their understanding of concepts related to the subject.[ES] En línea con las teorías de aprendizaje actuales, la enseñanza en la Educación Superior emplea cada vez más enfoques y actividades que sitúan al alumno en el centro del proceso de aprendizaje-enseñanza. Uno de estos enfoques es la gamificación: el uso de principios normalmente encontrados en juegos en un contexto ajeno al juego con fines educativos. Este trabajo considera el uso de una actividad de gamificación, Room Escape. La actividad se utiliza dentro de la asignatura Procedimientos Generales en Fisioterapia en el Grado de Fisioterapia de la Universidad San Jorge. Se adoptó un enfoque de Aprendizaje Basado en Casos y las características habituales del Room Escape fueron adaptadas para facilitar los resultados de aprendizaje deseados. Se realizó un cuestionario anónimo online para evaluar las percepciones de los estudiantes sobre sus ganancias de aprendizaje y la eficacia de la actividad como herramienta de aprendizaje. Los resultados muestran una evaluación positiva, particularmente en términos del grado de motivación y esfuerzo, aspectos clave para el éxito del aprendizaje. Los estudiantes reconocieron que podrían haberse preparado mejor pero que la actividad facilitó el aprendizaje con su enfoque de estudio de casos permitiéndoles consolidar su comprensión de conceptos relacionados con el tema.Jiménez Sánchez, C.; Lafuente Ureta, R.; Ortiz Lucas, M.; Bruton, L.; Millán Luna, V. (2017). Room Escape: Propuesta de Gamificación en el Grado de Fisioterapia. En In-Red 2017. III Congreso Nacional de innovación educativa y de docencia en red. Editorial Universitat Politècnica de València. 537-551. https://doi.org/10.4995/INRED2017.2017.6855OCS53755

CIBERER : Spanish national network for research on rare diseases: A highly productive collaborative initiative

Altres ajuts: Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovación.CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in the National Health System. CIBERER, the thematic area of CIBER focused on rare diseases (RDs) currently consists of 75 research groups belonging to universities, research centers, and hospitals of the entire country. CIBERER's mission is to be a center prioritizing and favoring collaboration and cooperation between biomedical and clinical research groups, with special emphasis on the aspects of genetic, molecular, biochemical, and cellular research of RDs. This research is the basis for providing new tools for the diagnosis and therapy of low-prevalence diseases, in line with the International Rare Diseases Research Consortium (IRDiRC) objectives, thus favoring translational research between the scientific environment of the laboratory and the clinical setting of health centers. In this article, we intend to review CIBERER's 15-year journey and summarize the main results obtained in terms of internationalization, scientific production, contributions toward the discovery of new therapies and novel genes associated to diseases, cooperation with patients' associations and many other topics related to RD research

Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

Objectives: This study aimed to assess the real use of cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) in the Spanish National Endocarditis Database (GAMES) and to compare it with antistaphylococcal penicillin (ASP). Methods: Prospective cohort study with retrospective analysis of a cohort of MSSA IE treated with cloxacillin and/or cefazolin. Outcomes assessed were relapse; intra-hospital, overall, and endocarditis-related mortality; and adverse events. Risk of renal toxicity with each treatment was evaluated separately. Results: We included 631 IE episodes caused by MSSA treated with cloxacillin and/or cefazolin. Antibiotic treatment was cloxacillin, cefazolin, or both in 537 (85%), 57 (9%), and 37 (6%) episodes, respectively. Patients treated with cefazolin had significantly higher rates of comorbidities (median Charlson Index 7, P <0.01) and previous renal failure (57.9%, P <0.01). Patients treated with cloxacillin presented higher rates of septic shock (25%, P = 0.033) and new-onset or worsening renal failure (47.3%, P = 0.024) with significantly higher rates of in-hospital mortality (38.5%, P = 0.017). One-year IE-related mortality and rate of relapses were similar between treatment groups. None of the treatments were identified as risk or protective factors. Conclusion: Our results suggest that cefazolin is a valuable option for the treatment of MSSA IE, without differences in 1-year mortality or relapses compared with cloxacillin, and might be considered equally effective